JOSUE MENDOZA: Open Payments
NPI 1467965707 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,307 in 109 payments from 14 companies in 2025. Trend: 2023 $2,096 · 2024 $2,165 · 2025 $2,307
Food & beverage: $2,284Education: $23
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $330 |
| Insmed, Inc. | 13 | $320 |
| AstraZeneca Pharmaceuticals LP | 12 | $299 |
| United Therapeutics Corporation | 8 | $227 |
| Verona Pharma, Inc. | 13 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $157 |
| Grifols USA, LLC | 5 | $122 |
| Baxter Healthcare | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
Products named: Arikayce, Tyvaso, Ohtuvayre, OFEV, DUPIXENT, NUCALA, TRELEGY ELLIPTA, GLASSIA.
Industry payments across TN — which companies pay providers there.
